211 related articles for article (PubMed ID: 7270561)
21. Assessing duration of antihypertensive effects with whole-day blood pressure monitoring.
Cheung DG; Gasster JL; Weber MA
Arch Intern Med; 1989 Sep; 149(9):2021-5. PubMed ID: 2673118
[TBL] [Abstract][Full Text] [Related]
22. Perindopril plus nifedipine versus perindopril plus hydrochlorothiazide in mild to severe hypertension: a double-blind multicentre study. The Multicentre Study Group on Treatment Association with Perindopril.
Letellier P; Overlack A; Agnes E; Desche P
J Hum Hypertens; 1994 Feb; 8(2):145-9. PubMed ID: 8207741
[TBL] [Abstract][Full Text] [Related]
23. A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
Gleim GW; Rubino J; Zhang H; Shahinfar S; Soffer BA; Lyle PA; Littlejohn TW; Feig PU
Clin Ther; 2006 Oct; 28(10):1639-48. PubMed ID: 17157119
[TBL] [Abstract][Full Text] [Related]
24. Increased efficacy and tolerability with losartan plus hydrochlorothiazide in patients with uncontrolled hypertension and therapy-related symptoms receiving two monotherapies.
Naidoo DP; Sareli P; Marin F; Aroca-Martinez G; Maritz FJ; Jardim PC; Guerrero AA; Thompson CA; Bero T; Drazka J; Kosmalova V; Dumortier T; Smith RD
Adv Ther; 1999; 16(5):187-99. PubMed ID: 10915394
[TBL] [Abstract][Full Text] [Related]
25. Losartan and low-dose hydrochlorothiazide in patients with essential hypertension. A double-blind, placebo-controlled trial of concomitant administration compared with individual components.
MacKay JH; Arcuri KE; Goldberg AI; Snapinn SM; Sweet CS
Arch Intern Med; 1996 Feb; 156(3):278-85. PubMed ID: 8572837
[TBL] [Abstract][Full Text] [Related]
26. A general practice study of timolol/hydrochlorothiazide/amiloride ('Moducren'), a new therapy for hypertension, and the doctor's influence on management.
Parry EE; Arr S; Tait D
Pharmatherapeutica; 1983; 3(5):294-9. PubMed ID: 6844366
[TBL] [Abstract][Full Text] [Related]
27. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B
Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
[TBL] [Abstract][Full Text] [Related]
28. Antiproteinuric and blood pressure-lowering effects of a fixed-dose combination of losartan and hydrochlorothiazide in hypertensive patients with stage 3 chronic kidney disease.
Abe M; Okada K; Maruyama T; Matsumoto K
Pharmacotherapy; 2009 Sep; 29(9):1061-72. PubMed ID: 19698011
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of a combination of enalapril and hydrochlorothiazide in the treatment of hypertension measured manually and with an ambulatory blood pressure monitor.
Weir MR; Lavin PT; Byrnes CA
Clin Ther; 1993; 15(3):527-38. PubMed ID: 8364944
[TBL] [Abstract][Full Text] [Related]
30. Enalapril and enalapril-hydrochlorothiazide in the treatment of essential hypertension. The Enalapril-Hydrochlorothiazide in Essential Hypertension Canadian Working Group.
Clin Ther; 1993; 15(2):364-73. PubMed ID: 8519044
[TBL] [Abstract][Full Text] [Related]
31. Renin inhibition with aliskiren provides additive antihypertensive efficacy when used in combination with hydrochlorothiazide.
Villamil A; Chrysant SG; Calhoun D; Schober B; Hsu H; Matrisciano-Dimichino L; Zhang J
J Hypertens; 2007 Jan; 25(1):217-26. PubMed ID: 17143194
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
Sachse A; Verboom CN; Jäger B
J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506
[TBL] [Abstract][Full Text] [Related]
33. Long-term antihypertensive efficacy and safety of the oral direct renin inhibitor aliskiren: a 12-month randomized, double-blind comparator trial with hydrochlorothiazide.
Schmieder RE; Philipp T; Guerediaga J; Gorostidi M; Smith B; Weissbach N; Maboudian M; Botha J; van Ingen H
Circulation; 2009 Jan; 119(3):417-25. PubMed ID: 19139391
[TBL] [Abstract][Full Text] [Related]
34. Double-blind, parallel, comparative multicentre study of a new combination of diltiazem and hydrochlorothiazide with individual components in patients with mild or moderate hypertension.
Manning G; Joy A; Mathias CJ; McDonald CJ; Millar-Craig MW
J Hum Hypertens; 1996 Jul; 10(7):443-8. PubMed ID: 8880557
[TBL] [Abstract][Full Text] [Related]
35. Antihypertensive effect of hydrochlorothiazide administered once or twice daily.
Allen JH; McKenney JM; Stratton MA; Link K
Clin Pharm; 1982; 1(3):239-43. PubMed ID: 6764388
[TBL] [Abstract][Full Text] [Related]
36. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
[TBL] [Abstract][Full Text] [Related]
37. Losartan potassium as initial therapy in patients with severe hypertension.
Dunlay MC; Fitzpatrick V; Chrysant S; Francischetti EA; Goldberg AI; Sweet CS
J Hum Hypertens; 1995 Nov; 9(11):861-7. PubMed ID: 8583463
[TBL] [Abstract][Full Text] [Related]
38. Combined action of enalapril or timolol with hydrochlorothiazide plus amiloride in hypertension.
Lumme JA; Jounela AJ
Ann Clin Res; 1987; 19(5):344-50. PubMed ID: 2831788
[TBL] [Abstract][Full Text] [Related]
39. Comparative antihypertensive effects of ketanserin and a ketanserin-hydrochlorothiazide combination administered once daily.
Leary WP; Reyes AJ; van der Byl K; Maharaj B
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S127-34. PubMed ID: 2446061
[TBL] [Abstract][Full Text] [Related]
40. Enalapril maleate and atenolol combined with hydrochlorothiazide in moderate to severe essential hypertension.
Pascoe J; Moon R; Gray D; Musgrove J
N Z Med J; 1985 Nov; 98(790):951-3. PubMed ID: 3001605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
